Team:Fatih Turkey/Experiments

From 2011.igem.org

(Difference between revisions)
 
(46 intermediate revisions not shown)
Line 59: Line 59:
}
}
table{
table{
 +
        background: transparent;
margin-top: 15px;
margin-top: 15px;
margin-bottom: 15px;
margin-bottom: 15px;
Line 480: Line 481:
});
});
</script>
</script>
-
 
+
<div class="body-2" id="top">
-
<div class="body-2">
+
<!-- Header -->
<!-- Header -->
<div id="header-whole">
<div id="header-whole">
Line 503: Line 503:
</li>
</li>
<li>
<li>
-
<a href="https://2011.igem.org/Team:Fatih_Turkey/Project">Project<span>Rainbow Graveyard</span></a>
+
<a href="https://2011.igem.org/Team:Fatih_Turkey/Project">Project</a>
<ul>
<ul>
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Project">Overall Project</a></li>
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Project">Overall Project</a></li>
Line 510: Line 510:
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Biofilm">Biofilm</a></li>
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Biofilm">Biofilm</a></li>
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments">Experiments</a></li>
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments">Experiments</a></li>
-
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Results">Results</a></li>
+
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Parts">Parts</a></li>
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Future_Plan">Future Plan</a></li>
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Future_Plan">Future Plan</a></li>
</ul>
</ul>
</li>
</li>
<li>
<li>
-
<a href="https://2011.igem.org/Team:Fatih_Turkey/Biobricks">Biobricks</a>
+
<a href="https://2011.igem.org/Team:Fatih_Turkey/Data_Page">Data Page</a>
-
<ul>
+
</li>
-
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Parts">Parts</a></li>
+
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Team">Team</a>
-
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Devices">Devices</a></li>
+
<ul>
-
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Modelling">Modelling</a></li>
+
                                                                                <li><a  
-
</ul>
+
href="https://2011.igem.org/Team:Fatih_Turkey/Members">Members</a></li>
-
</li>
+
                                                                                  <li><a  
-
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Safety">Safety</a></li>
+
href="https://2011.igem.org/Team:Fatih_Turkey/Gallery">Gallery</a></li>
 +
                                                                                  <li><a  
 +
href="https://2011.igem.org/Team:Fatih_Turkey/Europe_Jamboree">Europe Jamboree</a></li>
 +
</ul>
 +
</li>
<li>
<li>
<a href="https://2011.igem.org/Team:Fatih_Turkey/Human_Practice">Human Practice</a>
<a href="https://2011.igem.org/Team:Fatih_Turkey/Human_Practice">Human Practice</a>
<ul>
<ul>
-
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Sporocide">Sporocide</a></li>
+
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/Sporocide">Sporicide</a></li>
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/iGEM_for_7_to_77">iGEM for 7 to 77</a></li>
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/iGEM_for_7_to_77">iGEM for 7 to 77</a></li>
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/game">Game</a></li>
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/game">Game</a></li>
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/canvas_times">Canvas Times</a></li>
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/canvas_times">Canvas Times</a></li>
 +
                                                                                <li><a
 +
href="https://2011.igem.org/Team:Fatih_Turkey/Safety">Safety</a></li>
 +
<li><a href="https://2011.igem.org/Team:Fatih_Turkey/collaboration">Collaboration</a></li>
</ul>
</ul>
</li>
</li>
Line 539: Line 546:
</ul>
</ul>
</li>
</li>
-
</ul>
+
                                                            </ul>
</div>
</div>
</div>
</div>
Line 548: Line 555:
<div class="bar-title-whole">
<div class="bar-title-whole">
  <div class="bar-title">
  <div class="bar-title">
-
      <h2 style="font-family: Verdana, Arial, SunSans-Regular, sans-serif;">Project</h2>
+
      <h2 style="font-family: Verdana, Arial, SunSans-Regular, sans-serif;">Experiments</h2>
-
      <h5 style="font-family: Verdana, Arial, SunSans-Regular, sans-serif;">Experiments</h5>
+
      <h5 style="font-family: Verdana, Arial, SunSans-Regular, sans-serif;">Charactarization</h5>
    </div>
    </div>
  <div class="bar-title-sh-left"></div>
  <div class="bar-title-sh-left"></div>
Line 557: Line 564:
</div>
</div>
<div id="container">
<div id="container">
-
<div id="page">
+
            <div id="page">
-
<div class="page-wrapper">
+
              <div class="page-wrapper">
-
<!-- post container -->
+
    <div style="position: relative;">
-
<div>
+
        <div style="float: left; width: 220px; border-radius: 10px; position: absolute; top: 50px; left: 0; background: #EEE; border: solid 3px #666;">
-
<div class="meta-left-full">
+
            <ol>
-
<h3><strong>Experiment  of liquid culture</strong></h3><br>
+
              <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/confirmation">Charactarization</a></li>
-
&nbsp;&nbsp;&nbsp;We wanted to see the effects of supernatant of B.subtilis which produces LALF  in order to stop  e.coli with RFP growth in liquid culture.<br>
+
             
-
&nbsp;&nbsp;&nbsp;We put 8 ml LB broth in falcons.<br>
+
              </li>
-
&nbsp;&nbsp;&nbsp;We planned 3 control groups.These are:
+
             
-
<ul>
+
           
-
<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Control group 1:Includes only 5ul  e.coli which waited for  12 hours in 37⁰C. These can synthesize RFP.</li>
+
                  <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments1">Exposure Experiment</a></li>
-
<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Control group 2:Includes only 5 ul b.subtilis which produces LALF. They waited for 12 hours in 37⁰C.</li>
+
                 
-
<li>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Control group 3:Includes only 5ul b.subtilis which do not produce LALF. They waited for 12 hours in 37⁰C.</li>
+
               
-
</ul>
+
                  <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiment3C">Inhibition in Liquid Culture Assay</a></li>
-
&nbsp;&nbsp;&nbsp;First of all, we put 5ul e.coli which has RFP into 8 falcons as experimental groups. We waited experimental falcons for 12 hours in 37⁰C . Then, we added 1ul,10ul,100ul and 1000ul liquid culture with LALF and liquid culture without LALF. After this, we incubated them in 37⁰C and measured their OD value 2-4-8-12 hours later in 405 nm. Their results are as below:<br>
+
                  <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments4">Inhibition in Supernatant Assay</a></li>
-
<img src="https://static.igem.org/mediawiki/2011/e/ee/Graphicexp1.jpg" /><br>
+
<li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments2">The Suicide Experiment of E.Coli</a></li>  
-
Graph1 : Absorbance(OD405) value difference through time of AntiLPS-LPS binding  with 1 ul LALF<br>
+
                  <li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments5">Fenton Reagent Assay</a></li>
 +
<li type="A"><a href="https://2011.igem.org/Team:Fatih_Turkey/Experiments6">Existence of Reflectin</a></li>
 +
             
 +
            </ol>
 +
        </div>
 +
        <div style="width: 654px; border: solid 3px #666; border-radius: 10px; padding-left: 80px; margin-left: 170px;">
 +
            <table width="606" height="203" border="0">
 +
  <tr>
 +
    <td width="600" valign="top"><p><strong>CHARACTERIZATION</strong><br />
 +
<p><center><img src="https://static.igem.org/mediawiki/2011/5/59/Chrac.png" width="500" /></center></p>
 +
      <p>Before starting assays; we needed to be sure that our genes had been cloned  correctly. In order to use our parts in our experiments, we confirmed our parts  via electrophoresis. Following parts are fully confirmed:</p>
 +
      <table border="1" cellspacing="0" cellpadding="0">
 +
        <tr>
 +
          <td width="307" height="35" valign="top"><strong>Subparts</strong> </td>
 +
          <td width="307" valign="top"><p><strong>Parts</strong></p></td>
 +
        </tr>
 +
        <tr>
 +
          <td width="307" valign="top"><p>BBa_K541501</p></td>
 +
          <td width="307" valign="top"><p>BBa_K541515</p></td>
 +
        </tr>
 +
        <tr>
 +
          <td width="307" valign="top"><p>BBa_K541502</p></td>
 +
          <td width="307" valign="top"><p>BBa_K541545</p></td>
 +
        </tr>
 +
        <tr>
 +
          <td width="307" valign="top"><p>BBa_K541503</p></td>
 +
          <td width="307" valign="top"><p>BBa_K541596</p></td>
 +
        </tr>
 +
        <tr>
 +
          <td width="307" valign="top"><p>BBa_K541504</p></td>
 +
          <td width="307" valign="top"><p>BBa_K541915</p></td>
 +
        </tr>
 +
        <tr>
 +
          <td width="307" valign="top"><p>BBa_K541505</p></td>
 +
          <td width="307" valign="top"><p>BBa_K541800</p></td>
 +
        </tr>
 +
        <tr>
 +
          <td width="307" valign="top"><p>BBa_K541506</p></td>
 +
          <td width="307" valign="top"><p>BBa_K541516</p></td>
 +
        </tr>
 +
        <tr>
 +
          <td width="307" valign="top"><p>&nbsp;</p></td>
 +
          <td width="307" valign="top"><p>BBa_K541526</p></td>
 +
        </tr>
 +
        <tr>
 +
          <td width="307" valign="top"><p>&nbsp;</p></td>
 +
          <td width="307" valign="top"><p>BBa_K541546</p></td>
 +
        </tr>
 +
      </table>
 +
      <p>After electrophoresis results; we furthermore performed sequencing and  imaging tests to characterize our BioBricks. For BBa_541505 and BBa_541506; we  added a GFP sequence and transformated into E.coli. This has characterized our  main proteins. cDNA sequencing for these parts was also done successfully.<br />
 +
        In addition, BBa_541800 is transformated into B.subtilis and successfully  imaged red that shows RFP region and therefore plasmid backbone works properly.<br />
 +
    We characterized BBa_K541545, BBa_K541515 and BBa_K541915 via sequencing.</p></td>
 +
  </tr>
 +
</table>
 +
<p><center><img src="https://static.igem.org/mediawiki/2011/b/bc/Jelgoruntusu.jpg" width="500" /></center></p>
 +
<br>
 +
<br>
 +
        </div>
 +
    </div>
-
<img src="https://static.igem.org/mediawiki/2011/f/fb/Graphicexp2.jpg" /><br>
+
          </div>
-
Graph2 : Absorbance(OD405) value difference through time of AntiLPS-LPS binding  with 10 ul LALF<br>
+
-
 
+
-
<img src="https://static.igem.org/mediawiki/2011/f/f1/Graphicexp3.jpg" /><br>
+
-
Graph3 : Absorbance(OD405) value difference through time of AntiLPS-LPS binding  with 100 ul LALF<br>
+
-
 
+
-
<img src="https://static.igem.org/mediawiki/2011/b/b4/Graphicexp4.jpg" /><br>
+
-
Graph4 : Absorbance(OD405) value difference through time of AntiLPS-LPS binding  with 1000 ul LALF<br>
+
-
<hr>
+
-
<img src="https://static.igem.org/mediawiki/igem.org/d/db/M1.jpg" /><br>
+
-
1: This part includes a gram positive promoter, an RBS sequence and SacB signal peptide sequence to synthesize the protein outside of the cell. This image shows that indicated part is considered as confirmed.
+
-
<hr>
+
-
<img src="https://static.igem.org/mediawiki/2011/c/cd/M2.jpg" /><br>
+
-
2:This part includes a gram positive promoter, an RBS sequence and LipA signal peptide sequence to synthesize the protein outside of the cell. This image shows that indicated part is considered as confirmed.
+
-
<hr>
+
-
<img src="https://static.igem.org/mediawiki/2011/7/77/M3.jpg" /><br>
+
-
3: This part includes a constitutive promoter, an RBS sequence and Tat signal peptide sequence to synthesize the protein outside of the cell. This image shows that indicated part is considered as confirmed.
+
-
<hr>
+
-
<img src="https://static.igem.org/mediawiki/2011/5/5d/M4.jpg" /><br>
+
-
4:This part includes a IPTG inducible promoter, an RBS sequence and Tat signal peptide sequence to synthesize the protein outside of the cell. This image shows that indicated part is considered as confirmed.
+
-
<hr>
+
-
<img src="https://static.igem.org/mediawiki/2011/4/49/M5.jpg" /><br>
+
-
5:Our “LALF (limulus anti-lipopolysaccharide factor)” protein allows stopping any kind of gram negative bacteria growth by binding their cell wall material, LPS. This image shows that indicated part is considered as confirmed.
+
-
<hr>
+
-
<img src="https://static.igem.org/mediawiki/2011/6/6c/M6.jpg" /><br>
+
-
6:Our “reflectin” protein has the ability to reflect the light by changing its wavelength, thus its color. In our project, we planned to use this protein as an indicator on E.coli whether our LALF protein works properly or not. This image shows that indicated part is considered as confirmed.
+
-
<hr>
+
-
<img src="https://static.igem.org/mediawiki/2011/6/6c/M7.jpg" /><br>
+
-
8:This part is a well-studied gram positive promoter. We planned to use this gene in the case of our signal peptide sequences do not work. When the protein, which is attached to this gene, is produced, we planned to blow up the bacteria; therefore synthesized protein would be in supernatant. This image shows that indicated part is considered as confirmed.
+
-
 
+
-
<hr>
+
-
<img src="https://static.igem.org/mediawiki/igem.org/0/07/M8.jpg" /><br>
+
-
500: To perform cloning perfectly, we used pSB1C3 in E.coli. This vector is also the main vector for our parts that works only in E.coli. All of our parts are also inserted into this vector; because it is declared that all parts must be sent to Registry in pSB1C3. This image shows that this part is confirmed.
+
-
 
+
-
<hr>
+
-
<img src="https://static.igem.org/mediawiki/2011/c/c0/Ms4.png" /><br>
+
-
501: To perform ligation procedure appropriately, we designed an alternative part for all of our material parts. We inserted our promoters and proteins into pSB1C3 in order to have the alternative part that possesses different antibiotic resistance, comparing to original vectors of the parts. Moreover, it is wanted that all parts must be sent to Registry in pSB1C3. This part includes a gram positive promoter, RBS sequence and SacB signal peptide sequence. In the image, it can be seen that this part is confirmed.
+
-
 
+
-
<hr>
+
-
<img src="https://static.igem.org/mediawiki/2011/6/61/M10.jpg" /><br>
+
-
502: To perform ligation procedure appropriately, we designed an alternative part for all of our material parts. We inserted our promoters and proteins into pSB1C3 in order to have the alternative part that possesses different antibiotic resistance, comparing to original vectors of the parts. Moreover, it is wanted that all parts must be sent to Registry in pSB1C3. This part includes a gram positive promoter, RBS sequence and LipA signal peptide sequence. In the image, it can be seen that this part is confirmed.
+
-
 
+
-
<hr>
+
-
<img src="https://static.igem.org/mediawiki/2011/4/48/M11.jpg" /><br>
+
-
505:To perform ligation procedure appropriately, we designed an alternative part for all of our material parts. We inserted our promoters and proteins into pSB1C3 in order to have the alternative part that possesses different antibiotic resistance, comparing to original vectors of the parts. Moreover, it is wanted that all parts must be sent to Registry in pSB1C3. This part includes the sequence of our LALF protein. In the image, it can be seen that this part is confirmed.
+
-
 
+
-
<hr>
+
-
<img src="https://static.igem.org/mediawiki/2011/a/aa/M12.jpg" /><br>
+
-
506:To perform ligation procedure appropriately, we designed an alternative part for all of our material parts. We inserted our promoters and proteins into pSB1C3 in order to have the alternative part that possesses different antibiotic resistance, comparing to original vectors of the parts. Moreover, it is wanted that all parts must be sent to Registry in pSB1C3. This part includes the sequence of our reflectin protein. In the image, it can be seen that this part is confirmed.
+
-
 
+
-
<hr>
+
-
<img src="https://static.igem.org/mediawiki/2011/2/25/M13.jpg" /><br>
+
-
800: In our project, we planned to use gram positive bacteria to synthesize our LALF protein in order to stop gram negative growth. On the other hand, to identify effectively whether our protein works or not, we decided to use reflectinprotein and to produce it from both of our bacteria; B.subtilis and E.coli. Thus, we determined to use a shuttle vector that works both bacteria kinds. This vector has ampicillin resistance for E.coli and chloramphenicol resistance for B.subtilis. In the image, it can be seen that this part is confirmed.
+
-
 
+
-
<hr>
+
-
<img src="https://static.igem.org/mediawiki/2011/a/a0/Ms3.png" /><br>
+
-
900:In our project, we planned to use gram positive bacteria to synthesize our LALF protein in order to stop gram negative growth. On the other hand, to identify effectively whether our protein works or not, we decided to use reflectin protein and to produce it from both of our bacteria; B.subtilis and E.coli. Thus, we determined to use a shuttle vector that works both bacteria kinds. This vector has chloramphenicol resistance for both of bacteria kinds. This part also includes an RFP sequence. In the image, it can be seen that this part is confirmed.
+
-
<hr>
+
-
 
+
-
<img src="https://static.igem.org/mediawiki/igem.org/a/a5/M16.jpg" /><br>
+
-
545: This part is designed; because it is wanted that all parts must be sent to headquarters in pSB1C3 vector. It possesses a promoter that works in gram negative bacteria, Tat signal sequence in order to synthesize the protein outside and LALF protein gene.  In this image, indicated part is considered as confirmed.
+
-
<hr>
+
-
 
+
-
<img src="https://static.igem.org/mediawiki/2011/6/64/Ms2.png" /><br>
+
-
815: In order to stop gram negative bacteria growth, our LALF protein must be synthesized by another type of bacteria, gram positive. Thus, we designed a special gene that works in only gram positive bacteria by inserting a promoter specialized for gram positive. Also, SacB signal sequence that allows us synthesizing the protein outside and LALF protein gene is included.All components are inserted into 800 that isdesigned for gram positive. In this image, indicated part is considered as confirmed
+
-
<hr>
+
-
 
+
-
<img src="https://static.igem.org/mediawiki/2011/6/6c/Ms1.png" /><br>
+
-
915: In order to stop gram negative bacteria growth, our LALF protein must be synthesized by another type of bacteria, gram positive. Thus, we designed a special gene that works in only gram positive bacteria by inserting a promoter specialized for gram positive. Also, SacB signal sequence that allows us synthesizing the protein outside and LALF protein gene is included.All components are inserted into 900 that is designed for gram positive. In this image, indicated part is considered as confirmed.
+
-
<hr>
+
-
 
+
-
<img src="https://static.igem.org/mediawiki/2011/5/54/M18.jpg" /><br>
+
-
925:In order to stop gram negative bacteria growth, our LALF protein must be synthesized by another type of bacteria, gram positive. Thus, we designed a special gene that works in only gram positive bacteria by inserting a promoter specialized for gram positive. Also, LipA signal sequence that allows us synthesizing the protein outside and LALF protein gene is included.All components are inserted into 900 that is designed for gram positive. In this image, indicated part is considered as confirmed.
+
-
 
+
-
<hr>
+
-
 
+
-
<img src="https://static.igem.org/mediawiki/2011/3/30/M19.jpg" /><br>
+
-
516: This part is designed; because all parts must be sent to headquarters in pSB1C3 vector. In this image, indicated part is considered as confirmed.
+
-
 
+
-
<hr>
+
-
 
+
-
<img src="https://static.igem.org/mediawiki/2011/5/5c/M20.jpg" /><br>
+
-
526: This part is designed; because all parts must be sent to headquarters in pSB1C3 vector.In this image, indicated part is considered as confirmed.
+
-
 
+
-
<hr>
+
-
 
+
-
<img src="https://static.igem.org/mediawiki/2011/d/d9/M21.jpg" /><br>
+
-
536:In our experiments, we aimed to indicate whether our LALF protein works or not, we used an alternative indicator protein, reflectin. This part is designed to work in gram negative E.coli. A constitutive promoter, a Tat signal sequence that allows synthesizing the protein outside and reflectin protein gene is included in pSB1C3. In this image, indicated part is considered as confirmed.
+
-
 
+
-
<hr>
+
-
 
+
-
<img src="https://static.igem.org/mediawiki/2011/3/3b/M22.jpg" /><br>
+
-
546:In our experiments, we aimed to indicate whether our LALF protein works or not, we used an alternative indicator protein, reflectin. This part is designed to work in gram negative E.coli. An IPTG inducible promoter, a Tat signal sequence that allows synthesizing the protein outside and reflectin protein gene is included in pSB1C3. In this image, indicated part is considered as confirmed.
+
-
 
+
-
<hr>
+
-
 
+
-
<img src="https://static.igem.org/mediawiki/igem.org/8/85/M23.jpg" /><br>
+
-
596:In our experiments, we aimed to indicate whether our LALF protein works or not, we used an alternative indicator protein, reflectin. We designed an alternative part in the case that our signal sequences do not work. This part includes a promoter that works in only gram negative and reflectin protein gene. All components are inserted into pSB1C3. In this image, indicated part is considered as confirmed.
+
-
 
+
-
</div>
+
-
    </div>
+
       </div>
       </div>
</div>
</div>
-
</div>
 
-
 
<div class="footer-sh-wrapper">
<div class="footer-sh-wrapper">
<div class="footer-sh-left"></div>
<div class="footer-sh-left"></div>

Latest revision as of 01:36, 29 October 2011

deneme baslik

Experiments

Charactarization

CHARACTERIZATION

Before starting assays; we needed to be sure that our genes had been cloned correctly. In order to use our parts in our experiments, we confirmed our parts via electrophoresis. Following parts are fully confirmed:

Subparts

Parts

BBa_K541501

BBa_K541515

BBa_K541502

BBa_K541545

BBa_K541503

BBa_K541596

BBa_K541504

BBa_K541915

BBa_K541505

BBa_K541800

BBa_K541506

BBa_K541516

 

BBa_K541526

 

BBa_K541546

After electrophoresis results; we furthermore performed sequencing and imaging tests to characterize our BioBricks. For BBa_541505 and BBa_541506; we added a GFP sequence and transformated into E.coli. This has characterized our main proteins. cDNA sequencing for these parts was also done successfully.
In addition, BBa_541800 is transformated into B.subtilis and successfully imaged red that shows RFP region and therefore plasmid backbone works properly.
We characterized BBa_K541545, BBa_K541515 and BBa_K541915 via sequencing.



2011 © Fatih Medical School

Retrieved from "http://2011.igem.org/Team:Fatih_Turkey/Experiments"